Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
17/05/2011 | 12:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
17/05/2011 | 00:24 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
16/05/2011 | 22:41 | Edgar (US Regulatory) | Termination of Registration of a Class of Security under Section 12(g) (15-12G) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
16/05/2011 | 22:09 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
16/05/2011 | 19:33 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (SC 13D/A) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
16/05/2011 | 17:40 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
16/05/2011 | 17:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
16/05/2011 | 15:33 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
13/05/2011 | 21:39 | Edgar (US Regulatory) | Amended Statement of Ownership: Solicitation (SC 14D9/A) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
13/05/2011 | 16:54 | Edgar (US Regulatory) | Amended tender offer statement by Third Party (SC TO-T/A) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
13/05/2011 | 15:38 | Dow Jones News | Merck Gets Warm Tender Reception In $430 Million Inspire Purchase | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
10/05/2011 | 18:40 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
10/05/2011 | 12:30 | Business Wire | Inspire Reports First Quarter 2011 Financial Results | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
29/04/2011 | 14:30 | Zacks | Merck Tops on Lower Costs - Analyst Blog | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
28/04/2011 | 14:30 | Business Wire | Merck and Inspire Announce Expiration of Hart-Scott-Rodino Act Waiting Period Relating to Tender Offer for Shares of Inspire | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
26/04/2011 | 16:30 | Zacks | Merck: Earnings Preview - Analyst Blog | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
22/04/2011 | 13:44 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
22/04/2011 | 12:30 | Business Wire | Inspire Postpones Annual Meeting of Stockholders Due to Recently Announced Tender Offer | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
15/04/2011 | 22:13 | Edgar (US Regulatory) | Written communication relating to an issuer or third party (SC TO-C) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
15/04/2011 | 21:07 | Edgar (US Regulatory) | Written communication by the subject company relating to a third party tender offer (SC14D9C) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
15/04/2011 | 15:05 | Edgar (US Regulatory) | Statement of Ownership: Solicitation (SC 14D9) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
15/04/2011 | 15:01 | Business Wire | Merck Commences Tender Offer for all Outstanding Shares of Inspire Pharmaceuticals, Inc. | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
15/04/2011 | 14:51 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
15/04/2011 | 14:51 | Edgar (US Regulatory) | Tender offer statement by Third Party (SC TO-T) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
08/04/2011 | 16:06 | Business Wire | The Law Offices of Vincent Wong Announce an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Ph... | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
08/04/2011 | 12:03 | Edgar (US Regulatory) | Amended Securities Registration (section 12(b)) (8-A12B/A) | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
07/04/2011 | 22:11 | Business Wire | Faruqi & Faruqi, LLP Announces Shareholder Investigation Related to the Acquisition of Inspire Pharmaceuticals, Inc. - ISPH | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
07/04/2011 | 21:36 | Business Wire | The Law Firm of Weiss & Lurie Investigates the Acquisition of Inspire Pharmaceuticals, Inc. | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
07/04/2011 | 05:30 | Business Wire | Law Office of Brodsky & Smith, LLC Announces Investigation of Inspire Pharmaceuticals, Inc. | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |
07/04/2011 | 00:09 | Business Wire | The Law Office of Abe Shainberg Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Inspire Ph... | NASDAQ:ISPH | Inspire Pharmaceuticals, Inc. (MM) |